DAVID POPLACK to Risk
This is a "connection" page, showing publications DAVID POPLACK has written about Risk.
Connection Strength
0.038
-
Very high-dose methotrexate (33.6 g/m(2)) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144P. Leuk Lymphoma. 2006 Dec; 47(12):2488-504.
Score: 0.015
-
Acute lymphoblastic leukemia in childhood. Pediatr Clin North Am. 1985 Jun; 32(3):669-97.
Score: 0.013
-
Pregnancy outcome following cancer chemotherapy. Am J Med. 1980 Dec; 69(6):828-32.
Score: 0.010